Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309087 · ClinicalTrials.gov registry record
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA
A clinical trial of Lung Cancer, sponsored by Allegro Diagnostics.
- Completed
- Registry status
- 756
- Enrollment target
- 14
- Study locations
NCT01309087: Completed study of Lung Cancer, sponsored by Allegro Diagnostics.
NCT01309087 is a study of Lung Cancer that has completed, run by Allegro Diagnostics. The registered enrollment target is 756 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (19% lower). The trial reports 14 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01309087, a study of Lung Cancer, has completed, sponsored by Allegro Diagnostics.
- COMPLETED
- Registry status
- 756 participants
- Enrollment target
- 14
- Study locations
Study Summary
The primary objective of this study is to substantiate prediction accuracy(with a tighter 95% confidence interval compared to current diagnostic modalities), of a lung cancer biomarker for risk stratification of patients into high and low risk categories to aid in clinical evaluation of the patient.
Conditions Studied
Study Locations (14)
New York
- New York University - New York
- Columbia University - New York
Pennsylvania
- University of Pennsylvania - Philadelphia
- Temple University - Philadelphia
Alabama
- University of Alabama - Birmingham
Georgia
- Georgia Lung Associates - Austell
Indiana
- Indiana University - Indianapolis
Louisiana
- LSU - New Orleans
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 756 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-05 |
What the finished NCT01309087 record still lists
NCT01309087 is an observational study that tracks outcomes without assigning an intervention. The registered 756 participants enrollment target is mid-sized for trials with a published cap, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (19% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01309087 lists 14 locations in 12 states (New York, Pennsylvania, Alabama).
Frequently Asked Questions
What is clinical trial NCT01309087 about?
NCT01309087 is a clinical study titled "Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA". The primary objective of this study is to substantiate prediction accuracy(with a tighter 95% confidence interval compared to current diagnostic modalities), of a lung cancer biomarker for risk stratification of patients into high and low risk categories to aid in clinical evaluation of the patient.
What is the current status of trial NCT01309087?
This trial is currently completed. The enrollment target is 756 participants. The study started on 2009-01. Estimated completion is 2013-05.
What conditions does trial NCT01309087 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT01309087?
This trial is sponsored by Allegro Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01309087 being conducted?
This trial has 14 study locations across Alabama, Georgia, Indiana, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01309087's enrollment target sits among peer trials
756 57th of 409 higher than 353 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia